en
Scientific article
English

Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency

Published inMolecular therapy, vol. 6, no. 6, p. 824-829
Publication date2002
Abstract

Major histocompatibility complex class II (MHCII) deficiency is a primary immunodeficiency resulting from defects in one of four different MHCII-specific transcription factors-CIITA, RFX5, RFXAP, and RFXANK. Despite this genetic heterogeneity, the phenotypical manifestations are homogeneous. It is frequently difficult to establish a definitive diagnosis of the disease on the basis of clinical and immunological criteria. Moreover, the phenotypical homogeneity precludes unambiguous identification of the regulatory gene that is affected. Identification of the four genes mutated in the disease has now allowed us to develop a rapid and straightforward diagnostic test for new MHCII-deficiency patients. This test is based on direct correction of the genetic defect by transduction of cells from patients with lentiviral vectors encoding CIITA, RFXANK, RFX5, or RFXAP. We have validated this approach by defining the molecular defects in two new patients. The RFXANK vector restored MHCII expression in a T cell line from one patient. The RFXAP vector corrected primary cells (PBL) from a second patient. Molecular analysis confirmed the presence of homozygous mutations in the RFXANK and RFXAP genes, respectively. Direct genetic correction represents a valuable tool for the diagnosis and classification of new MHCII-deficiency patients.

Keywords
  • Amino Acid Sequence
  • Base Sequence
  • Cell Line
  • DNA-Binding Proteins/ genetics/metabolism
  • Female
  • Gene Therapy
  • Genetic Complementation Test
  • Genetic Vectors/genetics
  • Histocompatibility Antigens Class II/ analysis/genetics
  • Humans
  • Immunologic Deficiency Syndromes/classification/ diagnosis/ genetics/pathology
  • Lentivirus/genetics
  • Male
  • Molecular Sequence Data
  • Nuclear Proteins
  • Reproducibility of Results
  • T-Lymphocytes/metabolism
  • Trans-Activators/ genetics/metabolism
  • Transcription Factors/ genetics/metabolism
  • Transduction, Genetic
Affiliation Not a UNIGE publication
Citation (ISO format)
MATHEUX, Franck et al. Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency. In: Molecular therapy, 2002, vol. 6, n° 6, p. 824–829. doi: 10.1006/mthe.2002.0804
Main files (1)
Article
accessLevelRestricted
Identifiers
ISSN of the journal1525-0016
544views
0downloads

Technical informations

Creation08/27/2010 1:35:30 PM
First validation08/27/2010 1:35:30 PM
Update time03/14/2023 4:04:26 PM
Status update03/14/2023 4:04:26 PM
Last indexation02/12/2024 7:21:05 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack